Aigen Investment Management, LP Arrowhead Pharmaceuticals, Inc. Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $658,144 - $906,329	25,120 Added 250.7%	35,140 $944,000
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $252,103 - $414,627	10,020 New	10,020 $357,000
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $586,251 - $853,168	-10,042 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$62.15 - $90.32 $411,557 - $598,099	6,622 Added 193.63%	10,042 $832,000
Q1 2021 May 11, 2021	BUY	$61.35 - $90.47 $209,817 - $309,407	3,420 New	3,420 $227,000
Q1 2020 May 08, 2020	SELL	$20.56 - $63.12 $532,956 - $1.64 Million	-25,922 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$28.14 - $73.01 $729,445 - $1.89 Million	25,922 New	25,922 $1.64 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.